Hi ALL,
We are about to start a new week.
Thought this article is interesting in many facets.
Have a read,. We are still in the running for a MPL CV-19 treatment.
The vaccine didn't help to stop the spread after the first jab, who says it will after the second jab?
Roll out MPL and we are miles ahead IMO then all vaccines combined.
The commercialization of MPL is be worth billions.
The question is, can the BOD's at PharmAust, get the job done?
Giving them the benefit of the doubt, yes.
The question is just how long before that happens.
Trading halt imminently...
As Always
Best
Mickey MouseSydney's first CV-19 case in weeks had vaccine before diagnosis.
A man who tested positive to Covid-19 in NSW’s first case of community-transmitted coronavirus in almost two months received a vaccine a week before returning a positive test.
NSW recorded its first case of Covid-19 in 55 days on Sunday after a 47-year-old Sydney man working at two quarantine hotels tested positive late on Saturday.
The man, a security guard, worked at the Sofitel in Wentworth and the Mantra Hotel in Haymarket. He also worked in an office.
Chief Health Officer Dr Kerry Chant said on Sunday the man received an initial dose of Pfizer vaccine on March 2. He has yet to receive his second shot.
“We wouldn't have expected his immune system to kick in for 12-14 days or potentially longer, and then the second dose of the Pfizer vaccine gives further enhancement to that immune response,” Dr Chant said.
- Forums
- ASX - By Stock
- PharmAust is on track for Oral CV-19 treatment?
Hi ALL,We are about to start a new week.Thought this article is...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 119713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 0.215 |
7 | 63630 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 119713 | 2 |
0.230 | 24215 | 3 |
0.235 | 50000 | 1 |
0.240 | 44200 | 1 |
0.245 | 55000 | 4 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online